Survey of stress ulcer prophylaxis
HealthData.Gov
Updated Oct 29, 2026
About this dataset
Background: No surveys of stress ulcer prophylaxis prescribing in the USA have been conducted since 1995. Since that time, the most comprehensive meta-analysis and largest randomized study to date concerning stress ulcer prophylaxis have been published.
Results:
Three hundred sixty-eight surveys were sent to all members of the
Section of Pharmacy and Pharmacology of the Society of Critical Care Medicine. One hundred fifty-three (42%) surveys were returned. Representatives from 86% of institutions stated that medications for stress ulcer prophylaxis are used in a majority (>90%) of patients admitted to the intensive care unit (ICU). Twenty-two per cent of institutions have recommendations for both ICU and non-ICU settings. Fifty-eight per cent of institutions stated that there was one preferred medication for stress ulcer prophylaxis, and in 77% of these histamine-2-antagonists were the most popular.
Conclusions:
There are wide variations in prescribing practices for stress
ulcer prophylaxis. Institutions should consult published literature and use pre-existing guidelines as templates for developing their own guidelines.
Data and resources (1)
- HTML
Official Government Data Source
Visit the original government dataset for complete information, documentation, and data access.
Modified Dec 27, 2025